PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2013

Amended Announcements
Please refer to the earlier announcement reference number: PB-131112-52121

PHARMANIAGA BERHAD

Financial Year End

31/12/2013
Quarter3
Quarterly report for the financial period ended30/09/2013
The figureshave not been audited

Remarks :
Revised attachment on the Quarterly Report due to the entitlement date and the Book Closure have been changed from 4 December 2013 to 5 December 2013.
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2013

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2013
30/09/2012
30/09/2013
30/09/2012
$$'000
$$'000
$$'000
$$'000
1Revenue
440,807
426,460
1,378,779
1,329,942
2Profit/(loss) before tax
13,461
28,493
59,990
99,066
3Profit/(loss) for the period
4,170
25,536
35,494
70,674
4Profit/(loss) attributable to ordinary equity holders of the parent
3,751
25,247
34,387
69,645
5Basic earnings/(loss) per share (Subunit)
1.45
9.75
13.28
26.90
6Proposed/Declared dividend per share (Subunit)
3.00
4.55
9.82
11.37


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.8300
1.8200

Remarks :
The weighted average number of ordinary shares for the purpose of the computation of the basic earnings per share, dividend per share and net assets per share had been adjusted retrospectively to reflect the company's share split and bonus issue which were completed on 5 June 2013.
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced19 Nov 2013  
CategoryFinancial Results
Reference NoPB-131119-CDEB1